| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ilona Kryczek | Q88866814 |
| P2093 | author name string | Shuang Wei | |
| Weiping Zou | |||
| P2860 | cites work | Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells | Q24538658 |
| IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells | Q24621753 | ||
| Essential role for CD103 in the T cell-mediated regulation of experimental colitis | Q24646106 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics | Q28268587 | ||
| Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
| Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor | Q28595009 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool | Q33736534 | ||
| Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter | Q33936032 | ||
| Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro | Q33942128 | ||
| IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation | Q33977594 | ||
| Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation | Q33993967 | ||
| Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells | Q34103579 | ||
| Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | Q34189120 | ||
| The role of chemokines in linking innate and adaptive immunity | Q34493082 | ||
| Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. | Q34515741 | ||
| Identification of regulatory T cells in tolerated allografts | Q34524237 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| Increase of regulatory T cells in the peripheral blood of cancer patients. | Q34531138 | ||
| Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer | Q34536176 | ||
| The potential role of interleukin-2 in patients with HIV infection | Q34630069 | ||
| IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients | Q34657691 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| Regulatory T cells under scrutiny | Q35092531 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Antigen-induced regulatory T cells in autoimmunity | Q35092544 | ||
| Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells | Q35580410 | ||
| Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease | Q35848458 | ||
| Tolerance, not immunity, crucially depends on IL-2. | Q35877199 | ||
| Regulatory T cells: friend or foe in immunity to infection? | Q35934156 | ||
| Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. | Q36073821 | ||
| Natural regulatory T cells and self-tolerance | Q36078038 | ||
| A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. | Q36078042 | ||
| Mechanisms of suppression by suppressor T cells | Q36078047 | ||
| Natural regulatory T cells in infectious disease | Q36078051 | ||
| Regulatory tolerance-mediating T cells in transplantation tolerance | Q73936053 | ||
| The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 | Q74650540 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice | Q78022304 | ||
| Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers | Q79157496 | ||
| Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD | Q81014631 | ||
| Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells | Q81040823 | ||
| Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells | Q81357564 | ||
| A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection | Q81675748 | ||
| Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells | Q36369731 | ||
| CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion | Q36399063 | ||
| Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells | Q36399149 | ||
| CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status | Q36399748 | ||
| Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. | Q36402501 | ||
| Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period | Q36402733 | ||
| Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 | ||
| Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia | Q36403785 | ||
| Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis | Q36403813 | ||
| Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
| Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity | Q38480730 | ||
| Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses | Q40427517 | ||
| Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma | Q40436418 | ||
| Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells | Q40498116 | ||
| Production and selection of B lymphocytes in bone marrow: lymphostromal interactions and apoptosis in normal, mutant and transgenic mice. | Q40502207 | ||
| Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta | Q40703783 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues | Q41764860 | ||
| Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo | Q42210265 | ||
| Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells | Q42947524 | ||
| Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial | Q43435642 | ||
| Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells | Q43713989 | ||
| Persistence of memory CD8 T cells in MHC class I-deficient mice | Q44698642 | ||
| Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. | Q46315215 | ||
| Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. | Q46499903 | ||
| Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells | Q47339163 | ||
| Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function | Q47579310 | ||
| CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. | Q47853213 | ||
| CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions | Q47915145 | ||
| L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. | Q50796687 | ||
| The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. | Q51024754 | ||
| Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. | Q51830522 | ||
| Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. | Q51994210 | ||
| CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4+ T-cell subset. | Q51995543 | ||
| Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients. | Q52020607 | ||
| Humoral immunity due to long-lived plasma cells. | Q52040025 | ||
| Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. | Q52524822 | ||
| Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. | Q52938162 | ||
| Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. | Q54403966 | ||
| Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. | Q54692947 | ||
| Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo | Q56902877 | ||
| CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid | Q56903335 | ||
| Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma | Q56903494 | ||
| Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma | Q56904280 | ||
| Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis | Q57350588 | ||
| Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma | Q73653007 | ||
| Bone marrow as a priming site for T-cell responses to blood-borne antigen | Q73791481 | ||
| CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression | Q73867902 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 426-431 | |
| P577 | publication date | 2006-03-14 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Regulatory T-cell compartmentalization and trafficking | |
| P478 | volume | 108 |
| Q53590158 | A subpopulation of CD103(pos) ICOS(pos) Treg cells occurs at high frequency in lymphopenic mice and represents a lymph node specific differentiation stage. |
| Q53078255 | Ag and IL-2 immune complexes efficiently expand Ag-specific Treg cells that migrate in response to chemokines and reduce localized immune responses. |
| Q33573450 | Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation |
| Q85932260 | Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection |
| Q36544794 | Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells |
| Q36580415 | An obligate cell-intrinsic function for CD28 in Tregs |
| Q37270469 | Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression |
| Q36379675 | Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo |
| Q35653129 | Bone marrow and the control of immunity |
| Q34012863 | CD4+CD25+ regulatory T cells in autoimmune arthritis |
| Q51968092 | CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. |
| Q46853695 | Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss |
| Q43025486 | Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. |
| Q57798462 | Characterization of immune cell subtypes in three commonly used mouse strains reveals gender and strain-specific variations |
| Q39599154 | Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells |
| Q37253953 | Chemokine responsiveness of CD4+ CD25+ regulatory and CD4+ CD25- T cells from atopic and nonatopic donors |
| Q39337489 | Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy |
| Q39100186 | Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study |
| Q40499786 | Comparative study of host response to chytridiomycosis in a susceptible and a resistant toad species |
| Q30436124 | Cutting edge: normal regional lymph node enrichment of antigen-specific regulatory T cells with autoimmune disease-suppressive capacity |
| Q38815289 | Cytotoxic CD8+ T cell ablation enhances the capacity of regulatory T cells to delay viral elimination in Theiler's murine encephalomyelitis. |
| Q58385159 | Defective aeroallergen surveillance by airway mucosal dendritic cells as a determinant of risk for persistent airways hyper-responsiveness in experimental asthma |
| Q35022538 | Dual roles of immune cells and their factors in cancer development and progression |
| Q48193895 | Dynamics of regulatory T cells (Tregs ) in patients with oral squamous cell carcinoma. |
| Q50765097 | Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation. |
| Q37448511 | Eosinophil and T cell markers predict functional decline in COPD patients |
| Q54271070 | Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency. |
| Q35914558 | Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. |
| Q54500409 | Functional defects of CD46-induced regulatory T cells to suppress airway inflammation in mite allergic asthma. |
| Q47708991 | Greater transforming growth factor-β in adult female SHR is dependent on blood pressure, but does not account for sex differences in renal T-regulatory cells |
| Q28071495 | Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia |
| Q83003156 | High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts |
| Q37223366 | Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells |
| Q46959827 | Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils |
| Q24656069 | Human T regulatory cell therapy: take a billion or so and call me in the morning |
| Q37937750 | IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. |
| Q39547267 | IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma |
| Q36204083 | Immune modulation of CD4(+)CD25(+) regulatory T cells by zoledronic acid |
| Q34400439 | Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance |
| Q36881206 | Immunotherapy with methyl gallate, an inhibitor of Treg cell migration, enhances the anti-cancer effect of cisplatin therapy |
| Q34026055 | Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure |
| Q33522245 | In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy |
| Q36465691 | In vivo depletion of CD4+CD25+ regulatory T cells in cats. |
| Q33770196 | Induced Regulatory T Cells Superimpose Their Suppressive Capacity with Effector T Cells in Lymph Nodes via Antigen-Specific S1p1-Dependent Egress Blockage |
| Q26781290 | Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity |
| Q52362459 | Induction of porcine reproductive and respiratory syndrome virus (PRRSV)-specific regulatory T lymphocytes (Treg) in the lungs and tracheobronchial lymph nodes of PRRSV-infected pigs. |
| Q40994190 | Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma |
| Q37171804 | Inhibitory B7-family molecules in the tumour microenvironment |
| Q41988896 | Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression. |
| Q37735221 | Interplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals |
| Q53315805 | Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). |
| Q91000079 | Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation |
| Q79780562 | Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo |
| Q50924443 | Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. |
| Q36822184 | Manipulating the chemokine-chemokine receptor network to treat cancer |
| Q37658886 | Mechanisms of T-cell inhibition: implications for cancer immunotherapy |
| Q34748331 | Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy |
| Q39636113 | Methyl Gallate Exhibits Potent Antitumor Activities by Inhibiting Tumor Infiltration of CD4+CD25+ Regulatory T Cells |
| Q34166539 | Migration of regulatory T cells toward airway epithelial cells is impaired in chronic rhinosinusitis with nasal polyposis |
| Q45885554 | Monocyte/macrophage lineage commitment and distribution are affected by the lack of regulatory T cells in scurfy mice. |
| Q39417189 | NR4A1-dependent Ly6Clow monocytes contribute to reducing joint inflammation in arthritic mice through Treg cells |
| Q83179770 | Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice |
| Q34331993 | New roads open up for implementing immunotherapy in mesothelioma |
| Q37246687 | Orchestrating the orchestrators: chemokines in control of T cell traffic |
| Q28075712 | PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations |
| Q37748077 | Pathogenic mechanisms of allergic inflammation: atopic asthma as a paradigm |
| Q38293612 | Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization. |
| Q82507261 | Platelets suppress Treg recruitment |
| Q36918364 | Possible Involvement of Foxp3(+) Regulatory T Cells in the Development of Immune-Mediated Pancreatitis in MRL/Mp Mice Treated with Polyinosinic:Polycytidylic Acid. |
| Q42280563 | Protection against allergic airway inflammation during the chronic and acute phases of Trichinella spiralis infection. |
| Q37716661 | Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation |
| Q38246755 | Recent advances on cellular therapies and immune modulators for graft-versus-host disease |
| Q35559050 | Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers. |
| Q37128687 | Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids |
| Q52715799 | Regulatory T Cells As Potential Targets for HIV Cure Research. |
| Q92489012 | Regulatory T cell adaptation in the intestine and skin |
| Q39823591 | Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival |
| Q26995751 | Regulatory T cell in stroke: a new paradigm for immune regulation |
| Q37981391 | Regulatory T cell migration during an immune response |
| Q38616499 | Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11). |
| Q43997915 | Regulatory T cells ameliorate cardiac remodeling after myocardial infarction |
| Q37338455 | Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development |
| Q38191610 | Regulatory T cells as immunotherapy |
| Q30434337 | Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney |
| Q82609485 | Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis |
| Q38068406 | Regulatory T cells in HIV infection: can immunotherapy regulate the regulator? |
| Q84073243 | Regulatory T cells in cancer |
| Q37903852 | Regulatory T cells in gastrointestinal tumors |
| Q36293791 | Regulatory T cells in induced sputum of asthmatic children: association with inflammatory cytokines |
| Q37973820 | Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? |
| Q33784969 | Regulatory T cells in multiple sclerosis and myasthenia gravis. |
| Q38619815 | Regulatory T cells in the immunotherapy of melanoma |
| Q37452133 | Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis |
| Q37049217 | Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? |
| Q38650704 | Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression |
| Q36177006 | Requirement for CD28 in Effector Regulatory T Cell Differentiation, CCR6 Induction, and Skin Homing |
| Q26798141 | Research Progress on Regulatory T Cells in Acute Kidney Injury |
| Q35242154 | Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells. |
| Q38096466 | Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells |
| Q27025680 | Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets |
| Q90642824 | Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis |
| Q41883588 | Selective deregulation in chemokine signaling pathways of CD4+CD25(hi)CD127(lo)/(-) regulatory T cells in human allergic asthma |
| Q34026203 | Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis |
| Q85570105 | Serum level of soluble fibrinogen-like protein 2 in renal allograft recipients with acute rejection: a preliminary study |
| Q40298537 | Sex and age as determinants of rat T-cell phenotypic characteristics: influence of peripubertal gonadectomy |
| Q39838078 | Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients. |
| Q38647749 | Successes and failures of chemokine-pathway targeting in rheumatoid arthritis |
| Q64890943 | T cell pathology in skin inflammation. |
| Q36618597 | T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression |
| Q37357113 | T-cell responses to survivin in cancer patients undergoing radiation therapy |
| Q41333491 | TCR sequences and tissue distribution discriminate the subsets of naïve and activated/memory Treg cells in mice |
| Q28263622 | TGF-beta: a mobile purveyor of immune privilege |
| Q33711191 | TLR signals promote IL-6/IL-17-dependent transplant rejection. |
| Q45706268 | TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages |
| Q84510945 | TRAIL is associated with impaired regulation of CD4+CD25- T cells by regulatory T cells in patients with rheumatoid arthritis |
| Q53639981 | Targeted deletion of regulatory T cells attenuates the protective effects of myocardial ischemic preconditioning in rats. |
| Q37983467 | Targeting regulatory T cells |
| Q64105357 | The Contribution of the Immune System in Bone Metastasis Pathogenesis |
| Q55162275 | The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response? |
| Q36317414 | The abnormal expression of CCR4 and CCR6 on Tregs in rheumatoid arthritis |
| Q37937045 | The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target? |
| Q99565360 | The crosstalk between circular RNAs and the tumor microenvironment in cancer metastasis |
| Q38288116 | The delicate balance of melanoma immunotherapy |
| Q37959968 | The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance |
| Q52764039 | The dietary form of choline during lactation affects maternal immune function in rats. |
| Q42656251 | The immune system in cancer metastasis: friend or foe? |
| Q36752196 | The role of natural regulatory T cells in infection |
| Q43825675 | Therapy with anti-TNFα antibody enhances number and function of Foxp3+ regulatory T cells in inflammatory bowel diseases |
| Q38005015 | Tissue-specific homing of immune cells in malignant skin tumors. |
| Q35792962 | Transient regulatory T-cells: a state attained by all activated human T-cells. |
| Q36192911 | Treg cells, life history, and diversity |
| Q27303853 | Trypanosoma cruzi Experimental Infection Impacts on the Thymic Regulatory T Cell Compartment |
| Q37028767 | Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance |
| Q37410025 | Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation |
| Q38097918 | Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells. |
| Q24318773 | XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma |
| Q81786069 | [Active immunotherapy of urologic malignancies and tumor-mediated immunosuppression] |
Search more.